Evidence map›Paper›PMID 37479705›Full record

ArticleNPJ systems biology and applications2023

Growth exponents reflect evolutionary processes and treatment response in brain metastases.

Beatriz Ocaña-Tienda, Julián Pérez-Beteta, Juan Jiménez-Sánchez, David Molina-García, Ana Ortiz de Mendivil, Beatriz Asenjo, David Albillo, Luis A Pérez-Romasanta, Manuel Valiente, Lucía Zhu and 6 more

Open access · goldAbstract read
In one paragraph

Article in NPJ systems biology and applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Beatriz Ocaña-TiendaUniversity of Castilla-La Mancha, Ciudad Real, Spain. Beatriz.Ocana@uclm.es.ORCID 0000-0001-8931-3836
Julián Pérez-BetetaUniversity of Castilla-La Mancha, Ciudad Real, Spain.ORCID 0000-0003-0317-6215
Juan Jiménez-SánchezUniversity of Castilla-La Mancha, Ciudad Real, Spain.
David Molina-GarcíaUniversity of Castilla-La Mancha, Ciudad Real, Spain.ORCID 0000-0002-6104-3894
Ana Ortiz de MendivilSanchinarro University Hospital, HM Hospitales, Madrid, Spain.
Beatriz AsenjoHospital Regional Universitario de Málaga, Málaga, Spain.
David AlbilloMD Anderson Cancer Center, Madrid, Spain.ORCID 0000-0002-4496-6849
Luis A Pérez-RomasantaSalamanca University Hospital, Salamanca, Spain.
Manuel ValienteBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Lucía ZhuBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Pedro García-GómezBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0003-0694-3942
Elisabet González-Del PortilloHospital Universitario La Paz, Madrid, Spain.
Manuel LlorenteMD Anderson Cancer Center, Madrid, Spain.
Natalia CarballoMD Anderson Cancer Center, Madrid, Spain.
Estanislao Arana *Fundación Instituto Valenciano de Oncología, Valencia, Spain.ORCID 0000-0002-1884-7854
Víctor M Pérez-García *University of Castilla-La Mancha, Ciudad Real, Spain.ORCID 0000-0002-6575-495X
University of Castilla-La Mancha · ESMD Anderson Cancer Center Madrid · ESSpanish National Cancer Research Centre · ESFundación Instituto Valenciano de Oncología · ESHM Hospitales · ESHospital Regional Universitario de Málaga · ESHospital Universitario La Paz · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal models with bounded-growth dynamics accurately. However, results for the growth of human cancers in patients are scarce. Our study mined a large dataset of 1133 brain metastases (BMs) with longitudinal imaging follow-up to find growth laws for untreated BMs and recurrent treated BMs. Untreated BMs showed high growth exponents, most likely related to the underlying evolutionary dynamics, with experimental tumors in mice resembling accurately the disease. Recurrent BMs growth exponents were smaller, most probably due to a reduction in tumor heterogeneity after treatment, which may limit the tumor evolutionary capabilities. In silico simulations using a stochastic discrete mesoscopic model with basic evolutionary dynamics led to results in line with the observed data.

Indexed as

Biological PhenomenaBrain NeoplasmsAnimalsComputer SimulationHumansMice

Identifiers

PMID37479705
PMCPMC10361973
OpenAlexW4385050438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.